Skip to main content
Equibles

BDMD · Baird Medical Investment Holdings Ltd · Metrics

Track BDMD — free

Use BDMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BDMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.47 -0.01 (-1.60%)
Rebalance outlook locked
Market Cap
$15.57M
Shares
32.11M
Volume · Oct 22 35.56K Avg daily vol (3M) 56.88K

BDMD metrics

58 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.45
Market cap
$15.57M

Price action

20 metrics
Price change (1W)
-24.5%
Price change (30D)
-42.7%
Price change (3M)
-55.6%
Price change (6M)
-73.4%
Price change (YTD)
-66.7%
Price change (1Y)
-70.2%
Trailing year
Price change (5Y)
—
52-week high
$3.44
52-week low
$0.44
Change from 52-week high
-86.8%
Change from 52-week low
+3.9%
Annualized volatility
122.1%
Annualized volatility (3M)
92.5%
Beta
1.5
RSI (14D)
24.0
Price vs SMA 50
-50.5%
Price vs SMA 200
-66.9%
Avg volume (3M)
56,880
Relative volume
0.6
Average dollar volume
$51,526

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
32.11M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 157.3%
P / book
0.4
reciprocal yield 223.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
85.6%
Operating margin
-58.5%
Trailing 12 months
Net margin
-121.0%
Gross profit (TTM)
$20.97M
Operating profit (TTM)
−$14.33M
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.09

Growth

11 metrics
Revenue growth YoY
-39.2%
Year over year
Net income growth YoY
-319.0%
Revenue (TTM)
$24.49M
Trailing 12 months
EPS growth YoY
-271.9%
Shares change YoY
+27.3%
Year over year · more shares
Revenue CAGR (3Y)
-13.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-87.0%
Return on assets
-39.1%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
-20.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$178,321
Total assets
$73.85M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
$14.34M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
58.6%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
39
13F filer change QoQ
+4
Institutional ownership
19.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.8%
Holder tenure
3.1
Price vs estimated holder cost
-45.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
23 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1982444 CUSIP G0705H103 Visit website Investor relations